US-based Emergent’s anthrax vaccine gets FDA clearance
HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.
HQ Team July 24, 2023: US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious.
HQ Team July 22, 2023: Urinary tract infections (UTIs) affect nearly one in two women at least once in their lifetime. The growing.
HQ Team July 22, 2023:A study suggests that constipation, a common early symptom in Parkinson’s diagnosis, may result from an abnormal microbiome in.
HQ Team July 20, 2023: The WHO has sounded a global alert on a batch of substandard cough syrup found in Cameroon, which.
HQ Team July 19, 2023: Researchers from Indiana University have made a significant breakthrough in understanding the genetic factors behind Alcohol Use Disorders.
HQ Team July 19, 2023: As the global climate continues to change, the impact of rising temperatures is becoming increasingly evident, not only.
HQ Team July 18, 2023: Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of.
HQ Team July 18, 2023: India has destroyed 140,000 kilograms of narcotics worth 23 billion rupees — a record for the highest quantity.
HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.